Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Linda H. Malkas | M | - |
CS-Keys, Inc.
CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University.
Indiana University
| 18 years |
Robert J. Hickey | M | - |
CS-Keys, Inc.
CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University.
Indiana University
| 18 years |
Kenneth Gyan | M | - |
Indiana University
| - |
Jon Trinidad | M | - |
Indiana University
| - |
Andrew Lauck | M | 38 |
Indiana University
| - |
Robert J. Feeney | M | 55 |
CS-Keys, Inc.
CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | - |
Tony Armstrong | M | - |
Indiana University
| - |
Kendra Abercombie | F | - |
Indiana University
| - |
Peter Kolbaum | M | - |
Indiana University
| - |
Alex Stralker | M | - |
Indiana University
| - |
Danielle DeSawal | F | - |
Indiana University
| - |
Bruce Sales | M | - |
Indiana University
| - |
Ethan Fairbanks | M | - |
Indiana University
| - |
Margaret Kiel-Morse | F | - |
Indiana University
| - |
Benjamin Chupps | M | - |
Indiana University
| - |
Alexandre Lopes | M | - |
Indiana University
| - |
Matt Hottell | M | - |
Indiana University
| - |
Jonathan Schlebach | M | - |
Indiana University
| - |
Anne Delgado | F | - |
Indiana University
| - |
Jose Antinao-Rojas | M | - |
Indiana University
| - |
Mark McConahay | M | - |
Indiana University
| - |
Katie Metz | F | - |
Indiana University
| - |
Amy Pickard | F | - |
Indiana University
| - |
Evelyn Gil | F | - |
Indiana University
| - |
Brent Gault | M | - |
Indiana University
| - |
Kimberly Mattioli | F | - |
Indiana University
| - |
Ronald Whitaker | M | 76 |
Indiana University
| 7 years |
Susan Siena | F | - |
Indiana University
| - |
Elizabeth Hebbard | F | - |
Indiana University
| - |
John Arthos | M | - |
Indiana University
| - |
Joanna Woronkowicz | F | - |
Indiana University
| - |
Betsy Stirratt | F | - |
Indiana University
| - |
Bret Rothstein | M | - |
Indiana University
| - |
Paul Gutjahr | M | - |
Indiana University
| - |
Justin Garcia | M | - |
Indiana University
| - |
Melissa Dickson | F | - |
Indiana University
| - |
Ed Dallis-Comentale | M | - |
Indiana University
| - |
Kristen Chuang | F | - |
Indiana University
| - |
Alain Barker | M | - |
Indiana University
| - |
Robert Billingham | M | - |
Indiana University
| - |
Andrew Bunger | M | - |
Indiana University
| - |
Marjorie Treff | F | - |
Indiana University
| - |
Julia Fox | F | - |
Indiana University
| - |
Jason Jedlicka | M | - |
Indiana University
| - |
Danielle DeSawall | F | - |
Indiana University
| - |
Cassandra Coble | F | - |
Indiana University
| - |
Heather Ormiston | F | - |
Indiana University
| - |
Carrie Docherty | F | - |
Indiana University
| - |
Dan Calarco | M | - |
Indiana University
| - |
Jeff Perotti | M | - |
Indiana University
| - |
Norman Hedges | M | - |
Indiana University
| - |
Alex Alexeev | M | - |
Indiana University
| - |
Stephen Wyrczynki | M | - |
Indiana University
| - |
Diana Dingman | F | - |
Indiana University
| - |
Gwendolyn Sams | F | - |
Indiana University
| - |
Kathryn Ernstberger | F | 61 |
Indiana University
| - |
Carrie J. L. Bates | F | - |
CS-Keys, Inc.
CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | - |
Paul O. Walker | M | - |
Indiana University
| - |
Michael Rippey | M | 66 |
Indiana University
| - |
Glenn J. Bingle | M | - |
Indiana University
| - |
Daniel F. Evans | M | 74 |
Indiana University
| - |
Stephen L. Ferguson | M | 60 |
Indiana University
| - |
R. Neff | M | 68 |
CS-Keys, Inc.
CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | - |
Harry L. Gonso | M | - |
Indiana University
| - |
Dan J. Broderick | M | - |
CS-Keys, Inc.
CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | - |
Stephen Burns | M | 80 |
Indiana University
| - |
David Shane | M | 76 |
Indiana University
| - |
Larry S. Wechter | M | - |
Indiana University
| - |
Nate L. Walton | M | 74 |
Indiana University
| - |
Susanne S. Ridlen | M | - |
Indiana University
| - |
Richard DiMarchi | M | 71 |
Indiana University
| 21 years |
Barry A. Polisky | M | 78 |
Indiana University
| - |
David Grange | M | 76 |
Indiana University
| - |
Joseph Scott Etzler | M | 71 |
Indiana University
| - |
Adam W. Herbert | M | 80 |
Indiana University
| 21 years |
Angie Duncan | F | - |
Indiana University
| - |
Robert T. Grand | M | - |
Indiana University
| - |
Dillon Kimmel | M | - |
Indiana University
| - |
Jean Bandos | F | - |
Indiana University
| - |
David L. Beré | M | 70 |
Indiana University
| - |
Natalie Techentin | F | - |
Indiana University
| - |
Julia Newnum | F | - |
Indiana University
| - |
Marie Johns | F | 72 |
Indiana University
| - |
Neil Powell | M | - |
Indiana University
| 5 years |
Michael Coyle | M | - |
Indiana University
| - |
Doug Rex | M | - |
Indiana University
| - |
James Glazier | M | - |
Indiana University
| - |
Jeffey Wilson | M | - |
Indiana University
| - |
David E. VanReken | M | - |
Indiana University
| - |
Nick James | M | - |
Indiana University
| - |
Dale Dellacqua | M | - |
Indiana University
| - |
Lauren Schnaper | M | - |
CS-Keys, Inc.
CS-Keys, Inc. Medical SpecialtiesHealth Technology CS-Keys is the leader in discovery and development of cancer diagnostics based on the science of the DNA Synthesome. As the greatest potential for reducing mortality of cancer lies in the detection of asymptomatic, early stage disease, as well as for residual disease after treatment, the discovery of new markers for this purpose holds significant promise. CS-Keys patented caPCNA antibody may be a powerful ally in helping pathologists achieve this objective. CS-Keys, Inc. is a private, Indianapolis-based biotechnology company focused on the discovery and development of 3rd generation cancer-associated biomarkers using proteomics. These biomarkers may be used to create products to enhance the diagnosis and treatment of patients with cancer. CS-Keys was founded in early 2006 to develop and commercialize products based on the founders research and licensed from Indiana University. | 18 years |
Jay Love | M | - |
Indiana University
| - |
Mervin C. Yoder | M | - |
Indiana University
| - |
Merrill A. Ritter | M | - |
Indiana University
| - |
Jeremy Ecenbarger | M | - |
Indiana University
| 18 years |
Mark D. Cowan | M | - |
Indiana University
| - |
Jerome H. Fleisch | M | - |
Indiana University
| - |
J. Enright | M | 61 |
Indiana University
| - |
Rahul Shrivastav | M | - |
Indiana University
| 7 years |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Derek J. Hoelz
- Personal Network